Author

Josh B. Cortopassi

Observed names: Josh B Cortopassi, Josh Cortopassi, Joshua Cortopassi

Institutions: University of Alabama at Birmingham, UAB Medicine

Observed institutions: University of Alabama at Birmingham Hospital, University of Alabama at Birmingham, Kirklin Clinic, UAB Medicine

ORCID: 0009-0007-8131-3947

Observed ORCID: 0009-0007-8131-3947

OpenAlex ID: A5116904072

Warfarin dose adjustment required after cannabidiol initiation and titration

2020 · Josh Cortopassi · American Journal of Health-System Pharmacy · 23

Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study

2026 · Lucinda P. Lawson, Cynthia A. Prows, et al. · The American Journal of Human Genetics · 7

The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments

2026 · Nita Limdi, T. Mark Beasley, et al. · The American Journal of Human Genetics · 6

Assessment of acute kidney injury in neurologically and traumatically injured intensive care patients receiving large vancomycin doses

2018 · CaseyC May, BethL Erwin, et al. · International Journal of Critical Illness and Injury Science · 4

Implementing Integrated Genomic Risk Assessments for Breast Cancer: Lessons Learned from the eMERGE Study

2025 · Cong Liu, Katherine Crew, et al. · medRxiv · 3

Improving the medication-use process for 23.4% sodium chloride

2018 · Beth L Erwin, Michael A Denaburg, et al. · American Journal of Health-System Pharmacy · 3

Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics study

2025 · Cong Liu, Katherine D Crew, et al. · JAMIA Open · 1

Additive value of polygenic risk and family history for coronary heart disease risk stratification in two diverse US cohorts

2026 · Mohammadreza Naderian, Johanna L. Smith, et al. · The American Journal of Human Genetics

Implementing a multi-ancestry polygenic risk score for coronary heart disease in a diverse cohort

2026 · Marwan Hamed, Mohammadreza Naderian, et al. · Genetics in Medicine

Using a translational data platform to create clinical-grade genome-informed risk assessments

2026 · Jennifer L Morse, Megan He, et al. · JAMIA Open

Analytic Choices Shape Genomic Risk Estimates from Electronic Health Records: Coronary Heart Disease in eMERGE IV

2026 · Jingheng H. Chen, Sarah A. Knerr, et al. · medRxiv

Impact of Genetic Risk Factors on Coronary Heart Disease Risk Across the Age Spectrum in Three Major Race/Ethnicity Groups in the United States

2025 · Mohammadreza Naderian, Johanna L. Smith, et al. · medRxiv

Abstract 4361633: Incorporation of Genetic Risk Factors for Coronary Heart Disease into Clinical Risk Calculators Improved Risk Prediction in Three Major Race/Ethnicity Groups in the United States

2025 · Mohammadreza Naderian, Johanna Smith, et al. · Circulation

Current Limitations of Electronic Health Record Systems in Supporting Pragmatic Clinical Trials: Insights from the eMERGE Consortium

2025 · Kavishwar B. Wagholikar, Jennifer Allen Pacheco, et al. · medRxiv

939: Large Vancomycin Doses (> 4 Grams/day) Are Not Associated With Acute Kidney Injury in the Neuro-icu

2017 · Casey May, Margaret Childress, et al. · Critical Care Medicine

987: Large Vancomycin Doses (> 4 Grams/day) Are Not Associated With Acute Kidney Injury in the Trauma Icu

2017 · Doug Wylie, Margaret Childress, et al. · Critical Care Medicine

Works count: 16

Citation count: 47

H-index: 4

I10-index: 1